Novocure and US Oncology Research Announce Collaboration on PANOVA-3 Trial for Patients with Advanced Pancreatic Cancer

ST. HELIER, JERSEY, U.K. and THE WOODLANDS, TEXAS, U.S. (August 15, 2018) – Novocure (NASDAQ: NVCR) and US Oncology Research are collaborating on PANOVA-3, a phase 3 pivotal trial testing the efficacy of Tumor Treating Fields combined with nab-paclitaxel and gemcitabine in patients with unresectabl...
Source: McKesson News - Category: Information Technology Source Type: news